Prof Kylie Gorringe
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
167 Scholarly works
17 Projects
HIGHLIGHTS
2026
Journal article
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.
DOI: 10.1016/j.xcrm.2026.1029412026
Journal article
Abstract B036: The Rare Ovarian Cancer Collaborative Analytics (ROCCA) platform: Advancing research through a federated data network
DOI: 10.1158/1538-7445.rareca26-b0362026
Journal article
Abstract A009: Integrating HER2-Targeted Antibody-Drug Conjugates into Mucinous Ovarian Cancer Treatment: A preclinical Assesstment
DOI: 10.1158/1538-7445.rareca26-a0092025
Research grants (ARC, NHMRC, MRFF)
Lineage Tracing to Identify Ovarian Cancer Cells of Origin
2022
Research grants (other domestic)
Harnessing Innate Immune Cells for Breast Cancer Prevention
2021
Research Grant
Discovering the Cell of Origin for Rare Ovarian Cancers
2012
Journal article
CONTRA: Copy number analysis for targeted resequencing
DOI: 10.1093/bioinformatics/bts146
RECENT SCHOLARLY WORKS
2026
Journal article
Molecular pathology of phyllodes tumours of the breast—much more than MED12
DOI: 10.1111/his.700982026
Journal article
Androgen steroidogenesis and functional effect in mucinous ovarian cancer cells, organoids and patient tumours
DOI: 10.1530/endoabs.117.p912026
Journal article
A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma
DOI: 10.1111/his.700022026
Journal article
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
DOI: 10.1002/path.64612025
Other
Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063352025
Other
Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063472025
Other
Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.30706368
RECENT PROJECTS
2025
Research grants (other domestic)
New Treatments for Mucinous Ovarian Carcinoma